Related Experiment Video

Updated: Aug 21, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

6 Years of shot reporting--its influence on UK blood safety

Dorothy Stainsby1, Lorna Williamson, Hilary Jones

  • 1Serious Hazards of Transfusion (SHOT) Steering Group and Standing Working Group, SHOT Office, Manchester Blood Centre, Manchester M13 9LL, UK. dorothy.stainsby@nbs.nhs.uk

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|October 27, 2004
PubMed

Insights

The Serious Hazards of Transfusion (SHOT) scheme monitors transfusion adverse events. Data shows transfusion process errors cause most ABO incompatible events, highlighting needs for improved blood safety.

Area of Science:

  • Transfusion Medicine
  • Patient Safety
  • Public Health Surveillance

Background:

  • Haemovigilance schemes are crucial for monitoring transfusion adverse effects.
  • The Serious Hazards of Transfusion (SHOT) scheme is a leading UK-based haemovigilance program established in 1996.

Purpose of the Study:

  • To analyze data from the Serious Hazards of Transfusion (SHOT) scheme.
  • To identify key adverse events and errors in blood transfusion processes.
  • To provide evidence for enhancing UK blood safety strategies.

Main Methods:

  • Analysis of 1630 reported transfusion events over six years.
  • Categorization of events to identify transfusion process errors and specific adverse outcomes.
  • Assessment of data to inform blood safety policy development.

Main Results:

  • 64% of analyzed events were attributed to errors within the transfusion process.
  • 193 instances of ABO incompatible transfusions were reported.
  • Identified transfusion-related acute lung injury, bacterial contamination of platelets, and transfusion-associated graft-versus-host disease as significant preventable causes of harm.

Conclusions:

  • The SHOT scheme effectively identifies critical areas for improvement in transfusion safety.
  • Reducing transfusion process errors is essential to prevent ABO incompatible events.
  • Data from haemovigilance programs like SHOT are vital for developing and implementing effective blood safety strategies.

More Related Videos

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Blood Types02:20

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...